FUS and non-small cell lung carcinoma: The pre-specified hypothesis tested in the study was that the expression levels of 3 selected TSGs from LUCA region (FUS1, NPRL2/G21 and RASSF1A) were decreased in primary non-small cell lung cancer with promoter hypermethylation as the responsible epigenetic mechanism of their silencing.